Sensyne Health signs SRA with Somerset NHS FT

Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Clinical AI company Sensyne Health plc has signed a five-year Strategic Research Agreement (SRA) with Somerset NHS Foundation Trust to help develop the application of clinical AI to patient care and new medicines. The trust will join six existing SRAs already signed with NHS trusts and a data access agreement signed with NHS Greater Glasgow and…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »